1. "Health Outcomes Research Group"
  2. "Ayca Gucalp"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (3)
  3. Book Section (1)
Groups
  1. Breast Medicine Service (15)
  2. Department of Medicine (15)
  3. Epidemiology and Biostatistics (15)
  4. Health Outcomes Research Group (15)
  5. Population Sciences Research Program (15)
  6. Solid Tumor Oncology Division (15)

More Groups

People
  1. Ayca Gucalp (15)
  2. Shari Goldfarb (9)
  3. Tiffany Traina (7)
  4. Diana Lake (6)
  5. Larry Norton (6)
  6. Monica Fornier (6)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (1)
  5. 2017 (5)
  6. 2016 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Annals of Oncology (2)
  3. Annals of Behavioral Medicine (1)
  4. Cancer Research (1)
  5. JAMA Network Open (1)
  6. Journal of Investigative Dermatology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. Oxford University Press (2)
  3. American Association for Cancer Research (1)
  4. American Medical Association (1)
  5. Elsevier Science, Inc. (1)
  6. Mosby Elsevier (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oral minoxidil for the treatment of late alopecia in cancer survivors
    Meeting Abstract

    Kuo, A. M. S.; Reingold, R. E.; Ketosugbo, K.; Pan, A.; Dusza, S. W.; Kraehenbuehl, L.; Gajria, D.; Lake, D. E.; Bromberg, J.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer
    Meeting Abstract

    Gucalp, A.; Boyle, L. A.; Alano, T.; Arumov, A.; Gounder, M. M.; Patil, S.; Feigin, K.; Edelweiss, M.; D'Andrea, G.; Bromberg, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • "A tool, not a crutch": Patient perspectives about IBM Watson for Oncology trained by Memorial Sloan Kettering
    Journal Article

    Hamilton, J. G.; Genoff Garzon, M.; Westerman, J. S.; Shuk, E.; Hay, J. L.; Walters, C.; Elkin, E.; Bertelsen, C.; Cho, J.; Daly, B.; more...
    Journal of Oncology Practice (2019)

    Fulltext@MSK | Save
  • The microbial flora of taxane therapy–associated nail disease in cancer patients
    Journal Article

    Virgen, C. A.; Belum, V. R.; Kamboj, M.; Goldfarb, S. B.; Blinder, V. S.; Gucalp, A.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2018)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • The microbial flora of taxane therapy-associated nail disease in cancer patients
    Meeting Abstract

    Virgen, C. A.; Belum, V. R.; Kamboj, M.; Goldfarb, S. B.; Blinder, V. S.; Gucalp, A.; Lacouture, M. E.
    Journal of Investigative Dermatology (2017)

    Fulltext@MSK | Save
  • "A tool, not a crutch': Patients with breast cancers' perceptions of the IBM Watson for Oncology clinical decision support system
    Meeting Abstract

    Hamilton, J. G.; Shuk, E.; Westerman, J. S.; Genoff, M. C.; Werk, R. S.; Pocus, V.; Hay, J. L.; Walters, C.; Elkin, E.; Gucalp, A.; more...
    Annals of Behavioral Medicine (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save